142
Views
1
CrossRef citations to date
0
Altmetric
Articles

Economic evaluation of stroke treatment in Italy: systematic literature review

ORCID Icon
Pages 365-374 | Received 07 Feb 2018, Accepted 09 Nov 2018, Published online: 02 Dec 2018

References

  • Sarti C, Rastenyte D, Cepaitis Z, et al. International trends in mortality from stroke, 1968 to 1994. Stroke. 2000;31:1588–1601. doi: 10.1161/01.STR.31.7.1588
  • ISTAT. Health for all – Italia. 2015. Available from: www.istat.it/it/archivio/14562/
  • Amaducci L, Baldereschi M, DiCarlo A, et al. Prevalence of chronic diseases in older Italians: comparing self-reported and clinical diagnoses. Int J Epidemiol. 1997;26(5):995–1002. doi: 10.1093/ije/26.5.995
  • Di Carlo A, Baldereschi M, Gandolfo C, et al. For the ILSA Working group. stroke in an elderly population. incidence and impact on survival and daily function. The Italian longitudinal study on aging. Cerebrovasc Dis. 2003;16:141–150. doi: 10.1159/000070594
  • Sudlow CLM, Warlow CP. International stroke incidence Collaboration. Comparable studies of the incidence of stroke and its pathological types results from an international collaboration. Stroke. 1997;28(3):491–499. doi: 10.1161/01.STR.28.3.491
  • Di Gianfilippo G, Napoli D, Santis D. L’ictus in Italia: Risultati a 5 Anni de L’Aquila stroke Registry (1994–1998) e confronto con studicomparabili di popolazionenazionaliedInternazionali per unapolitica di gestioneprogrammatadellapatologia. RivItalNeurobiol. 2006;2:109–136.
  • Evers SM, Struijs JN, Ament AJ, et al. International comparison of stroke cost studies. Stroke. 2004;35(5):1209–1215. doi: 10.1161/01.STR.0000125860.48180.48
  • Nichols M, Townsend N, Luengo-Fernandez R, et al. European cardiovascular disease statistics. Brussels: European Heart Network, European Society of Cardiology; 2012.
  • Capri S, Veneziano MA. Valutazione economica Rivaroxaban, in Rivaroxaban per la prevenzione dell’ictus in pazienti con fibrillazione atriale: risultati di una valutazione di HTA. Quaderni Dell'Italian Journal of Public Health. 2013;2(7):59–79.
  • Lucioni DC, Mazzi S, Micieli G, et al. Valutazioneeconomica del trattamento con alteplase di pazienti con ictus ischemico in faseacuta, con riferimentoall’Italia. PharmacoEconomics Italian Research Articles. 2010;12(2):91–103. doi: 10.1007/BF03320667
  • Ravasio R, Pedone MP, Ratti M. Analisi di costoefficaciadeinuovianticoagulantioralinellaprevenzionedell’ictus in pazienti con fibrillazioneatrialenon valvolare in Italia. PharmacoEconomics Italian Research Articles. 2014;16(2–3):1–10. doi: 10.1007/s40276-014-0022-x
  • Scaletti A, Lauro E, Belfiore P, et al. Impattoeconomicodelle stroke unit in Campania. Ig SanitàPubbl. 2014;70:73–96.
  • Bottacchi E, Corso G, Tosi P, et al. The cost of first-ever stroke in Valle d’Aosta, Italy: linking clinical registries and administrative data. BMC Health Serv Res. 2012;12(1):372–381. doi: 10.1186/1472-6963-12-372
  • Carinci F, Roti L, Francesconi P, et al. The impact of different rehabilitation strategies after major events in the elderly: the case of stroke and hip fracture in the Tuscany region. BMC Health Serv Res. 2007;7(1):95–102. doi: 10.1186/1472-6963-7-95
  • Cesaroni G, Agabiti N, Forastiere F, et al. Socioeconomic differences in stroke incidence and prognosis under a universal healthcare system. Stroke. 2009;40(8):2812–2819. doi: 10.1161/STROKEAHA.108.542944
  • Fattore G, Torbica A, Susi A, et al. The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study. BMC Neurol. 2012;12(1):137–144. doi: 10.1186/1471-2377-12-137
  • Häkkinen U, Rosenqvist G, Iversen T, et al. Outcome, use of resources and their relationship in the treatment of AMI, stroke and hip fracture at European hospitals. Health Econ. 2015;24(S2):116–139. doi: 10.1002/hec.3270
  • Hurst SA, Forde R, Reiter-Theil S, et al. Physicians’ views on resource availability and equity in four European health care systems. BMC Health Serv Res. 2007;7(1):137. doi: 10.1186/1472-6963-7-137
  • Mahoney EM, Wang K, Arnold SV, et al. Cost-Effectiveness of prasugrel versus clopidogrel in patients With acute Coronary Syndromes and planned Percutaneous Coronary intervention results from the trial to assess improvement in therapeutic outcomes by Optimizing Platelet Inhibition With prasugrel–thrombolysis in myocardial infarction TRITON-TIMI 38. Circulation. 2010;121(1):71–79. doi: 10.1161/CIRCULATIONAHA.109.900704
  • Masiero S, Poli P, Armani M, et al. Robotic Upper Limb rehabilitation after acute stroke by NeReBot: evaluation of treatment costs. Biomed Res Int. 2014;2014:1–9.
  • Mureddu GF, Tarantini L, Agabiti N, et al. Evaluation of different strategies for identifying asymptomatic left ventricular dysfunction and pre-clinical (stage B) heart failure in the elderly. results from ‘PREDICTOR’, a population based-study in central Italy. Eur J Heart Fail. 2013;15(10):1102–1112. doi: 10.1093/eurjhf/hft098
  • Piscitelli P, Iolascon G, Argentiero A, et al. Incidence and costs of hip fractures vs strokes and acute myocardial infarction in Italy: comparative analysis based on national hospitalization records. Clin Interv Aging. 2012;7:575. doi: 10.2147/CIA.S36828
  • Schuetz CA, Alperin P, Guda S, et al. A standardized vascular disease health check in Europe: a cost-effectiveness analysis. PloS one. 2013;8(7):e66454. doi: 10.1371/journal.pone.0066454
  • Hays AG, Sacco RL, Rundek T, et al. Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population. Stroke. 2006;37(7):1715–1719. doi: 10.1161/01.STR.0000227121.34717.40
  • Pulignano G, Del Sindaco D, Tinti MD, et al. Atrial fibrillation management in older heart failure patients: a complex clinical problem. Heart Int. 2016 Sep 22;11(1):e41–e49. doi: 10.5301/heartint.5000230
  • Boulton J, Akhtar N, Shuaib A, et al. Waiting for a stroke bed: Planning strokeunitcapacityusingqueuingtheory. Int J Healthc Manag. 2016;9(1):4–10. doi: 10.1080/20479700.2015.1101910
  • Viju R. An empirical investigation of chronic diseases: A visualization approach to Medicare in the United States. Int J Healthc Manag, 2018 – Issue 1;15(3):431.
  • Okpala P. Harnessing the power of collaborative leadership in the management of chronic health conditions. Int J Healthc Manag. 2017. doi:10.1080/20479700.2017.1414109.
  • Putrik P. Comparative study of chronic care in threeEuropeanregions: Basque country, Veneto Region, and Wales. Int J Healthc Manag. 2014;7(3):153–164. doi: 10.1179/2047971913Y.0000000063
  • Milchakov KS, Shilov E, Semenova J. Management of chronic kidney disease in the Russian Federation: A criticalreview of prevalence and preventive programmes. Int J Healthc Manag. 2018. doi:10.1080/20479700.2018.1453970.
  • VinaytoshMishra V, Samuel C, Sharma SK. Lean, agile an leagilehealthcare management – A case of chronic care. Int J Healthc Manag. 2018. doi:10.1080/20479700.2018.142852.
  • Romano-Spica V, Macini P, Fara GM, et al. Adapted physical activity for the promotion of health and the prevention of MultifactorialChronicDiseases: the Erice Charter. Ann Ig. 2015;27:406–414.
  • Liguori G, Belfiore P, D'Amora M, et al. The Principles of health technology assessment in laboratory medicine. Clin Chem Lab Med. 2017;55(1):32–37. ISSN (Print) 1434–6621. doi: 10.1515/cclm-2016-0371
  • Gallè F, Di Onofrio V, Romano Spica V, et al. Improving physical fitness and health status perception in community-dwelling older adults through a structured program for physical activity promotion in the city of Naples, Italy: a randomized controlled trial. Geriatr Gerontol Int. 2017;17:1421–1428. doi: 10.1111/ggi.12879

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.